Crystalloids, colloids, blood products and blood substitutes

被引:0
|
作者
Naisbitt, Christopher [1 ,2 ]
Mos, K. F. A.
Kishen, Roop [3 ]
机构
[1] Royal North Shore Hosp, St Leonards, NSW, Australia
[2] Griffith Univ, Nathan, Qld, Australia
[3] Salford Royal Fdn Trust, Salford, Lancs, England
来源
ANAESTHESIA AND INTENSIVE CARE MEDICINE | 2019年 / 20卷 / 06期
关键词
Blood; blood substitutes; coagulation; colloid; crystalloid; goal-directed fluid therapy; plasma; platelets; GOAL-DIRECTED RESUSCITATION; FLUID RESUSCITATION; 0.9-PERCENT SALINE; SURGERY; THERAPY; TRIAL;
D O I
10.1016/j.mpaic.2019.03.007
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Understanding the physiology of fluid distribution in the human body is fundamental to good clinical practice in anaesthesia and intensive care. Intravenous fluid therapies have a range of clinical and metabolic consequences and they should be context and patient specific. Inadequate or excessive fluid treatment is harmful to patients. There are numerous trials, both historical and current, investigating best practice in fluid therapy. New paradigms and guidelines are being published, and it is important for clinicians to keep up to date with current practice. There is a continued drive to improve the safety of donor blood and prevent transfusion errors. Knowledge of how blood products are collected, separated and stored is essential to prevent harm to patients through transfusions. The development of blood substitutes is progressing, with NHS trials involving stem cell originated red cells having begun.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 50 条